MiR-10b directly targets ZEB1 and PIK3CA to curb adenomyotic epithelial cell invasiveness via upregulation of E-cadherin and inhibition of Akt phosphorylation

Cellular Physiology and Biochemistry

Volumn 35, Issue 6, 2015, Pages 2169-2180

  Guo, Ying ^a   Lang, Xiao ^b   Lu, Zhen ^a   Wang, Jianchao ^a   Li, Ting ^a   Liao, Ying ^a   Jia, Chunyan ^a   Zhao, Wenxia ^c   Fang, Huiqi ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c Department of Urology Shanghai Jiangwan Hospital   (China)

Author keywords

Adenomyosis; Akt; E cadherin; MiR 10b

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 10B; P AKT PROTEIN; PHOSPHOPROTEIN; PIK3CA PROTEIN; PROTEIN; PROTEIN KINASE B; TRANSCRIPTION FACTOR ZEB1; TUMOR MARKER; UNCLASSIFIED DRUG; UVOMORULIN; CADHERIN; CDH1 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; MIRN10 MICRORNA, HUMAN; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3CA PROTEIN, HUMAN; TRANSCRIPTION FACTOR; ZEB1 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADENOMYOEPITHELIOMA; ADULT; ARTICLE; CELL INVASION; CELL INVASION ASSAY; CELL ISOLATION; CELL MIGRATION; CELL MIGRATION ASSAY; CLINICAL ARTICLE; DOWN REGULATION; ENDOMETRIUM; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; CASE CONTROL STUDY; CELL MOTION; CELL PROLIFERATION; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; PHOSPHORYLATION;

ADULT; CADHERINS; CASE-CONTROL STUDIES; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; ENDOMETRIUM; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84928138096     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000374022     Document Type: Article

References (27)

1. Arnold LL, Ascher SM, Schruefer JJ, Simon JA: The nonsurgical diagnosis of adenomyosis. Obstet Gynecol 1995;86:461-465.
2. Juang CM, Chou P, Yen MS, Twu NF, Horng HC, Hsu WL: Adenomyosis and risk of preterm delivery. BJOG 2007;114:165-169.
3. Benagiano G, Brosens I: The endometrium in adenomyosis. Womens Health (Lond Engl) 2012;8:301-312.
4. Chen YJ, Li HY, Huang CH, Twu NF, Yen MS, Wang PH, Chou TY, Liu YN, Chao KC, Yang MH: Oestrogen-induced epithelial-mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosis. J Pathol 2010;222:261-270.
5. Hayes J, Peruzzi PP, Lawler S: Micrornas in cancer: Biomarkers, functions and therapy. Trends Mol Med 2014;20:460-469.
6. Li G, Wu Z, Peng Y, Liu X, Lu J, Wang L, Pan Q, He ML, Li XP: Microrna-10b induced by epstein-barr virus-encoded latent membrane protein-1 promotes the metastasis of human nasopharyngeal carcinoma cells. Cancer Lett 2010;299:29-36.
7. Liao CG, Kong LM, Zhou P, Yang XL, Huang JG, Zhang HL, Lu N: Mir-10b is overexpressed in hepatocellular carcinoma and promotes cell proliferation, migration and invasion through rhoc, upar and mmps. J Transl Med 2014;12:234.
8. Ma L, Teruya-Feldstein J, Weinberg RA: Tumour invasion and metastasis initiated by microrna-10b in breast cancer. Nature 2007;449:682-688.
9. Sasayama T, Nishihara M, Kondoh T, Hosoda K, Kohmura E: Microrna-10b is overexpressed in malignant glioma and associated with tumor invasive factors, upar and rhoc. Int J Cancer 2009;125:1407-1413.
10. Tian Y, Luo A, Cai Y, Su Q, Ding F, Chen H, Liu Z: Microrna-10b promotes migration and invasion through klf4 in human esophageal cancer cell lines. J Biol Chem 2010;285:7986-7994.
11. Hiroki E, Akahira J, Suzuki F, Nagase S, Ito K, Suzuki T, Sasano H, Yaegashi N: Changes in microrna expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas. Cancer Sci 2010;101:241-249.
12. Tsukamoto 0, Miura K, Mishima H, Abe S, Kaneuchi M, Higashijima A, Miura S, Kinoshita A, Yoshiura K, Masuzaki H: Identification of endometrioid endometrial carcinoma-associated micrornas in tissue and plasma. Gynecol Oncol 2014;132:715-721.
13. Pan Q, Luo X, Toloubeydokhti T, Chegini N: The expression profile of micro-rna in endometrium and endometriosis and the influence of ovarian steroids on their expression. Mol Hum Reprod 2007;13:797-806.
14. Schneider C, Kassens N, Greve B, Hassan H, Schuring AN, Starzinski-Powitz A, Kiesel L, Seidler DG, Gotte M: Targeting of syndecan-1 by micro-ribonucleic acid mir-10b modulates invasiveness of endometriotic cells via dysregulation of the proteolytic milieu and interleukin-6 secretion. Fertil Steril 2013;99:871-881 e871.
15. Franco-Chuaire ML, Magda Carolina SC, Chuaire-Noack L: Epithelial-mesenchymal transition (emt): Principles and clinical impact in cancer therapy. Invest Clin 2013;54:186-205.
16. Polyak K, Weinberg RA: Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat Rev Cancer 2009;9:265-273.
17. Oh SJ, Shin JH, Kim TH, Lee HS, Yoo JY, Ahn JY, Broaddus RR, Taketo MM, Lydon JP, Leach RE, Lessey BA, Fazleabas AT, Lim JM, Jeong JW: Beta-catenin activation contributes to the pathogenesis of adenomyosis through epithelial-mesenchymal transition. J Pathol 2013;231:210-222.
18. Cakmak H, Guzeloglu-Kayisli O, Kayisli UA, Arici A: Immune-endocrine interactions in endometriosis. Front Biosci (Elite Ed) 2009;1:429-443.
19. Xue J, Zhang H, Liu W, Liu M, Shi M, Wen Z, Li C: Metformin inhibits growth of eutopic stromal cells from adenomyotic endometrium via ampk activation and subsequent inhibition of akt phosphorylation: A possible role in the treatment of adenomyosis. Reproduction 2013;146:397-406.
20. Cikos S, Bukovska A, Koppel J: Relative quantification of mrna: Comparison of methods currently used for real-time pcr data analysis. BMC Mol Biol 2007;8:113.
21. Zhang L, Rees MC, Bicknell R: The isolation and long-term culture of normal human endometrial epithelium and stroma. Expression of mrnas for angiogenic polypeptides basally and on oestrogen and progesterone challenges. J Cell Sci 1995;108 ( Pt 1):323-331.
22. Dong PX, Jia N, Xu ZJ, Liu YT, Li DJ, Feng YJ: Silencing of iqgap1 by shrna inhibits the invasion of ovarian carcinoma ho-8910pm cells in vitro. J Exp Clin Cancer Res 2008;27:77.
23. Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y, Zhuang SM: Microrna-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res 2009;69:1135-1142.
24. Dong P, Kaneuchi M, Xiong Y, Cao L, Cai M, Liu X, Guo SW, Ju J, Jia N, Konno Y, Watari H, Hosaka M, Sudo S, Sakuragi N: Identification of klfl7 as a novel epithelial to mesenchymal transition inducer via direct activation of twist1 in endometrioid endometrial cancer. Carcinogenesis 2014;35:760-768.
25. Dai L, Di W: [role of microrna in the occurrence and development of endometriosis]. Zhonghua Fu Chan Ke Za Zhi 2011;46:304-306.
26. Lin SC, Wang CC, Wu MH, Yang SH, Li YH, Tsai SJ: Hypoxia-induced microrna-20a expression increases erk phosphorylation and angiogenic gene expression in endometriotic stromal cells. J Clin Endocrinol Metab 2012;97:E1515-1523.
27. Grimbizis GF, Mikos T, Tarlatzis B: Uterus-sparing operative treatment for adenomyosis. Fertil Steril 2014;101:472-487.